drugset / Trial / NCT02983890
Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
RandomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted as a cocktail-study namely an open-label, randomized, two-sequence, two-period crossover, cocktail study where a combination of cocktail-drugs is used to illustrate whether or not, or to what degree dicloxacillin affects the level of activity of the 5 most important CYP enzymes and therefore plays a potentially decisive role in serious drug-drug interactions.
Timeline
- Start
- 2016-10-06
- Primary completion
- 2017-04-05
- Completion
- 2017-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dicloxacillin | Small molecule | 500 mg | — |
Indications
No indication recorded.